100th Episode & Counting
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 100″]
With 100 episodes and two years behind us, OIS Podcast brought together researchers, investors, physicians, and executives to assess the state of innovation and to reveal what developments they anticipate seeing in the next two years.
The podcast opens with an invigorating conversation between Jeffrey Goldberg, MD, professor and chair of ophthalmology at the Byers Eye Institute at Stanford University, and Leonard A. Levin, MD, chair of ophthalmology, McGill Faculty of Medicine, and chief of ophthalmology, McGill University Health Centre (MUHC).
The pair brings OIS Podcast up to speed on the Audacious Goals Initiative being funded by the National Eye Institute (NEI). The conversation then turns to the recent paper published in Nature Neuroscience citing experiments at Stanford that demonstrated that optic nerves can be regenerated, a study that suggests lost vision could be restored.
The podcast then looks into the more immediate future. Through discussions with KOLs, investors, executives, and experts, changes we might soon see in ophthalmology are presented. What issues will we be discussing in the next two years of OIS Podcasts?
We hope you enjoy this celebration of innovation in ophthalmology.
Anthony P. Adamis, MD
Anthony P. Adamis, M.D. is Senior Vice President and Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science at Genentech, a member of the Roche Group. Dr. Adamis is best known for his co-discovery of the role of VEGF in ocular disease.
Adnan is a senior biotechnology analyst at RBC Capital Markets. His current coverage universe and research interests encompass cardiology, infectious diseases, neuro-psychiatry, oncology, and ophthalmology, as well as other emerging areas and modalities.
Jay S. Duker, MD
Jay S. Duker, MD, is the Director of the New England Eye Center, Professor and Chairman of the Department of Ophthalmology at Tufts Medical Center and Tufts University School of Medicine in Boston, MA. Dr. Duker received his medical degree magna cum laude from Jefferson Medical College.
Tarek S. Hassan, MD
Tarek S. Hassan, M.D. is Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Fellowship Director at Associated Retinal Consultants in Royal Oak, Michigan. He is the current President of the American Society of Retina Specialists (ASRS) and is head of the Executive Committee of both the ASRS and the Foundation of the ASRS.
Mark S. Humayun, MD, PhD
Mark S. Humayun, MD, PhD, is the Cornelius J. Pings Chair in Biomedical Sciences, Professor of Ophthalmology, Biomedical Engineering and Cell and Neurobiology, Director of the USC Institute for Biomedical Therapeutics, and Co-Director of the USC Eye Institute.
Tracy Saxton is an Investment Director with the Roche Venture Fund (RVF). She currently serves on the boards of Lumos Pharmaceuticals, SutroVax Inc, Mission Therapeutics, Millendo Therapeutics and Purigen Biosystems.
Aron Shapiro is a Vice President at Ora, Inc., the world’s leading independent, full-service ophthalmic CRO and product development firm. He has served as a member of Ora’s Senior Management Team for the past 15 years.